Insider: Koenig Sheldon L. President and CEO - Esperion Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,172,699 | 0 | 2,172,699 |
| Value | $5,670,744.39 | $0.00 | $5,670,744.39 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/17/2026 | DDS | 25,578 | Direct | COM | $2.72 | $69,546.58 | 2,172,699 |
| 12/17/2025 | DDS | 48,244 | Direct | COM | $3.67 | $177,200.21 | 1,470,587 |
| 09/17/2025 | DDS | 28,427 | Direct | COM | $2.79 | $79,254.48 | 1,518,831 |
| 06/17/2025 | DDS | 30,474 | Direct | COM | $1.11 | $33,795.67 | 1,541,488 |
| 03/18/2025 | DDS | 13,047 | Direct | COM | $1.50 | $19,622.69 | 1,571,962 |
| 12/17/2024 | DDS | 12,447 | Direct | COM | $2.47 | $30,694.30 | 739,819 |
| 09/17/2024 | DDS | 14,550 | Direct | COM | $1.80 | $26,131.80 | 752,266 |
| 05/09/2023 | AAP | 20,000 | Direct | COM | $1.26 | $25,192.00 | 312,816 |
| 03/17/2023 | DDS | 6,999 | Direct | COM | $1.78 | $12,479.22 | 292,816 |
| 03/07/2023 | DDS | 5,441 | Direct | COM | $5.06 | $27,509.70 | 194,815 |
| 09/19/2022 | DDS | 3,394 | Direct | COM | $6.94 | $23,547.57 | 198,257 |
| 08/05/2022 | AAP | 8,606 | Direct | COM | $5.80 | $49,950.08 | 198,771 |
| 03/17/2022 | DDS | 571 | Direct | COM | $4.58 | $2,615.18 | 194,717 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research